Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Private Equity Strategies

New Ventures: SEB Venture Capital invests in 3D graphics business

Tuesday, July 23, 2013

By: Bailey McCann, Private Equity Strategies

The venture capital arm of SEB, the Northern European financial Group is getting into 3D with a new transaction. SEB Venture Capital has invested in Donya Labs AB, a global leader in optimization of 3D graphics for computer games. The new capital will enable accelerated growth and diversification towards computer-aided design (CAD), architecture and film.

SEB Venture Capital has been investing in venture capital transactions for the past 18 years. With a capital base of SEK 2.5bn, it currently has 28 portfolio companies within technology and life science and has completed 70 exits since inception.

“We already have an investment in this segment, that produces 2D and 3D graphics. So, we are quite familiar with the market, and we think that the market will grow including 3D printing especially in areas like CAD,” says Ulf Lewander, Investment Manager, SEB Venture Capital, in an interview with Private Equity Strategies.

Donya Labs AB has developed unique software called Simplygon, to automatically optimize advanced 3D graphics. Traditionally, optimization of 3D graphics has been expensive and time consuming as a manual process. By automatically optimizing 3D graphics for applications such as real-time visualization, interactivity and 3D printing, workflows can be streamlined and integrated.

“We believe the new business model which operates a cloud version of the technology will open a huge market opportunity,” Lewander says. “Right now the company only sells licensing to high end gaming companies. Those companies pay thousands of dollars per license, per game. We have been able to prove that one 3D model at a time done on the cloud is also justifiable.”

SEB Venture Capital has subscribed to a new share issue of SEK 10m focused on growing this cloud offer and adding new geographies to the company’s footprint. SEB and Donya Labs will be looking for additional subscribers in for a serial round B in the future.

Lewander notes that SEB Venture Capital is focused on finding companies like this that can move from one niche to a broader market. “We are looking for companies that have already proven themselves in tough spaces, going forward we think that will be mostly in software, not hardware.”

 
This article was published in Opalesque's Private Equity Strategies our monthly research update on the global private equity landscape including all sectors and market caps.
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies


Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its